Keyphrases
Promoter Sequence
100%
Microdeletion
100%
ASS1
100%
Citrullinemia Type I
100%
Romani
100%
CTLN1
80%
ASS1 Gene
30%
Sanger Sequencing
20%
Promoter Elements
20%
Pathogenic Variants
20%
Luciferase Reporter Assay
20%
PCR Amplification
20%
Coding Exons
20%
A2058 Cells
20%
Autosomal Recessive
10%
Ablation
10%
MRNA Expression
10%
Genetic Testing
10%
Peripheral Blood Lymphocytes
10%
Binding Site
10%
Life-threatening
10%
3′-untranslated Region (3′-UTR)
10%
HepG2
10%
Upstream Sequence
10%
TATA Box
10%
Molecular Characterization
10%
Argininosuccinate Synthetase
10%
Malignant Melanoma
10%
Exon 1
10%
Reduced Expression
10%
Non-coding Region
10%
Promoter Region
10%
HepG2 Cells
10%
Neurocognitive Impairment
10%
Urea Cycle Disorders
10%
Non-coding
10%
5′-untranslated Region (5′-UTR)
10%
Sequence Method
10%
Genomic DNA (gDNA)
10%
Biochemical Phenotype
10%
Reporter Expression
10%
Human Liver Cancer Cells
10%
Heterozygosity
10%
Biallelic
10%
Clinical Sequencing
10%
E-box
10%
Hyperammonemia
10%
Expression Plasmid
10%
Type Sequences
10%
Liver Cancer Cell Lines
10%
GC Box
10%
Clinical Genetic Testing
10%
Entire Sequence
10%
Targeted PCR
10%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Exon
50%
Wild Type
50%
Luciferase
50%
Pribnow Box
50%
Genetic Screening
50%
Dideoxynucleotide Sequencing
50%
Cancer Cell
25%
Binding Site
25%
Plasmid
25%
Peripheral Blood Lymphocyte
25%
Autosomal Recessive Inheritance
25%
TATA Box
25%
Coding Region
25%
Untranslated Region
25%
Urea Cycle Disorder
25%
Heterozygosity
25%
E-Box
25%
Argininosuccinate Synthase
25%
GC Box
25%
Genomics
25%
Messenger RNA
25%